Stigma, SocialNCT05878470
Reducing Self-stigma Using Brief Video Intervention
A study testing video in people with Stigma, Social and Mental Health Disorder, run by New York State Psychiatric Institute at 1 site in United States.
Trial summary
Stigma is a profound obstacle to care. Self-stigma decreases sense of self-competency, as well as healthcare seeking and treatment adherence and creates barriers to pursuing employment, independent living, and fulfilling social life. Read more about this study
- Who is it for?
- Ages 18 to 35 yearsHealthy volunteers can take part
- Conditions the study is for
- Stigma, Social, Mental Health Disorder
- What is being tested?
- video
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,214 participants
- Where
- 1 siteUnited States
- Study dates
- 25 Jan 2023to 7 Mar 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 35 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- English-speaking
- 18-35-year-old
- US residents
- Those who answered yes to "Do you have or have you had a diagnosed, ongoing mental health/illness/condition?"
Who cannot join
- Non English-speaking
- Non US residents
- Age younger than 18 or older than 35
- People who replied no to the question on ongoing mental health
Trial locations and contacts
1 site in 1 country.
United States1 site
New York State Psychiatric Institute
New York, New York, 10032
About this study
Stigma is a profound obstacle to care. Self-stigma decreases sense of self-competency, as well as healthcare seeking and treatment adherence and creates barriers to pursuing employment, independent living, and fulfilling social life. For example, people with mental disorders avoid, delay, or drop out of treatment due to a fear of labeling and discrimination or experience treatments as ineffective or disrespectful. Therefore, reducing self stigma can reduce self-blame, improve self-confidence and provide support for people living with mental illness.
In a prior study, the investigators developed a short video intervention to reduce self-stigma among people with schizophrenia. The investigators would like to test the efficacy of this video using Prolific (a crowdsourcing platform). Specifically, the investigators are interested in recruiting 1,200 Prolific participants, ages 18-35, who mentioned in their profile while enrolling to Prolific that they have a mental health condition, and randomized them into watching the newly developed video to reduce self-stigma or participate in the non-intervention control arm. Participants will be invited to participate in a follow-up survey 30 days after completing the first survey.
Read the detailed description
The primary objective of this study is to test the video efficacy in reducing self stigma among 1,200 Prolific users who mentioned in their profile while enrolling to Prolific that they have a mental health condition (600 in an intervention group, and 600 in a non-intervention control group). The study participants will be invited to participate in a 30-day follow up questionnaire. The investigators hypothesize finding a reduced level of self-stigma among those who watch the intervention video.
- Conditions
- Stigma, Social, Mental Health Disorder
- Being tested
- video
- Medical subject headings
- Social Stigma, Mental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
videoBehavioural
A brief (119 seconds) social contact-based video. The video presented a young Black man in his early twenties, a professional actor, sharing his scripted personal story of struggles with psychotic illness and raising themes of recovery and hope.
| Study group | Role | What they receive |
|---|---|---|
| Brief video intervention | Experimental | Brief (119 seconds) social contact-based video Receives: Behavioral: video |
| Non-intervention control | No intervention | Non-intervention control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self-stigma
The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.
Measured: Baseline
Self-stigma
The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.
Measured: Post (immediately after the intervention and for the control immediately after doing the baseline survey)
Self-stigma
The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.
Measured: 30 day follow up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2023
- Study start25 Jan 2023
- Primary completion7 Mar 2023
- Study completion7 Mar 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Stigma, SocialStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 1,214 participants (actual)
Sponsor and investigators
- Lead sponsor
- New York State Psychiatric Institute
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Doron Amsalem, New York State Psychiatric Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05878470
- Sponsor's protocol ID
- 8432
- Status last verified
- May 2023
- First submitted
- 9 May 2023
- Last updated
- 26 May 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Amsalem D, Jankowski SE, Yanos P, Yang LH, Markowitz JC, Rogers RT, Stroup TS, Dixon LB, Pope LG. Randomized Controlled Trial of a Brief Video Intervention to Reduce Self-Stigma of Mental Illness. J Clin Psychiatry. 2024 Mar 6;85(1):23m15034. doi: 10.4088/JCP.23m15034.
PubMed 38451170
Study at a glance
From the registry record, last updated by the sponsor on 26 May 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Reducing Self-stigma Using Brief Video Intervention
- ClinicalTrials.gov ID
- NCT05878470
- Acronym / sponsor ID
- 8432
- Conditions
- Stigma, Social, Mental Health Disorder
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 1,214 participants (actual)
- Lead sponsor
- New York State Psychiatric InstituteUniversity, hospital or other
- Study start
- 25 Jan 2023 (actual)
- Primary completion
- 7 Mar 2023 (actual)
- Study completion
- 7 Mar 2023 (actual)
- First posted
- 26 May 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Stigma is a profound obstacle to care. Self-stigma decreases sense of self-competency, as well as healthcare seeking and treatment adherence and creates barriers to pursuing employment, independent living, and fulfilling social life. For example, people with mental disorders avoid, delay, or drop out of treatment due to a fear of labeling and discrimination or experience treatments as ineffective or disrespectful. Therefore, reducing self stigma can reduce self-blame, improve self-confidence and provide support for people living with mental illness.
In a prior study, the investigators developed a short video intervention to reduce self-stigma among people with schizophrenia. The investigators would like to test the efficacy of this video using Prolific (a crowdsourcing platform). Specifically, the investigators are interested in recruiting 1,200 Prolific participants, ages 18-35, who mentioned in their profile while enrolling to Prolific that they have a mental health condition, and randomized them into watching the newly developed video to reduce self-stigma or participate in the non-intervention control arm. Participants will be invited to participate in a follow-up survey 30 days after completing the first survey.
Detailed description
The primary objective of this study is to test the video efficacy in reducing self stigma among 1,200 Prolific users who mentioned in their profile while enrolling to Prolific that they have a mental health condition (600 in an intervention group, and 600 in a non-intervention control group). The study participants will be invited to participate in a 30-day follow up questionnaire. The investigators hypothesize finding a reduced level of self-stigma among those who watch the intervention video.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Brief video intervention | Experimental | Behavioral: videoBrief (119 seconds) social contact-based video |
| Non-intervention control | No intervention | –Non-intervention control |
Who may qualify
- Ages
- 18 to 35 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (4 listed)
- English-speaking
- 18-35-year-old
- US residents
- Those who answered yes to "Do you have or have you had a diagnosed, ongoing mental health/illness/condition?"
Key exclusion criteria (4 listed)
- Non English-speaking
- Non US residents
- Age younger than 18 or older than 35
- People who replied no to the question on ongoing mental health
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| videoA brief (119 seconds) social contact-based video. The video presented a young Black man in his early twenties, a professional actor, sharing his scripted personal story of struggles with psychotic illness and raising themes of recovery and hope. | Behavioural | Brief video intervention |
Primary outcome
Self-stigma
Time frame: Baseline
The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.
Self-stigma
Time frame: Post (immediately after the intervention and for the control immediately after doing the baseline survey)
The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.
Self-stigma
Time frame: 30 day follow up
The investigators assessed self-stigma using 23 items across six domains: Stereotype Endorsement, Alienation, Stigma Resistance, Perceived Devaluation Discrimination, Secrecy, and Recovery Assessment Scale.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 May 2023.
- Derived from this study: PubMed 38451170Amsalem D, Jankowski SE, Yanos P, Yang LH, Markowitz JC, Rogers RT, Stroup TS, Dixon LB, Pope LG. Randomized Controlled Trial of a Brief Video Intervention to Reduce Self-Stigma of Mental Illness. J Clin Psychiatry. 2024 Mar 6;85(1):23m15034. doi: 10.4088/JCP.23m15034.
- Individual participant dataSharing planned: No
Related trials for Stigma, Social
Active, not recruiting
Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer
Cervical Cancer Screening
Not yet recruiting
Pilot Study to Co-create and Implement a Multicomponent Intervention to Reduce Mental Health Stigma in Primary Care
Mental Health, Stigma of Mental Illness
Not yet recruiting
Testing a Multi-Level Approach to Reduce Stigma for Women Living With HIV
HIV (Human Immunodeficiency Virus)
Not yet recruitingObservational study
Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders
Stigma of Mental Illness, Cancer
Recruiting
Reducing Mental Health Stigmatization Among Healthcare Workers and Students Using a Virtual Reality Protocol: The VIRTUS Protocol
Schizophrenia Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing video in people with Stigma, Social and Mental Health Disorder, run by New York State Psychiatric Institute at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 May 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self-stigma (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05878470, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 May 2023.